Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 9—September 2009
Research

Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006

Dounia Bitar, Dieter Van Cauteren, Fanny Lanternier, Eric Dannaoui, Didier Che, Francoise Dromer, Jean-Claude Desenclos, and Olivier Lortholary
Author affiliations: Institut de Veille Sanitaire, Saint Maurice, France (D. Bitar, D. Van Cauteren, D. Che, J.-C. Desenclos); Université Paris-Descartes, Paris, France (F. Lanternier, O. Lortholary); Institut Pasteur, Paris (E. Dannaoui, F. Dromer, O. Lortholary); Hôpital Georges Pompidou, Paris (E. Dannaoui).

Main Article

Table

Distribution of zygomycosis cases and deaths, by underlying disease, France, 1997–2006

Known risk factors No. cases No. deaths Case-fatality ratio, %*
Bone marrow transplantation
 33
 12
 36.4
Hematologic malignancies 59 21 35.6
Neutropenia/aplastic anemia 23 11 47.8
Acute lymphoid/myeloid leukemias 20 6 30.0
Other lymphoid/myeloid disorders
 16
 4
 25.0
Nonhematologic immunodepression 64 8 12.5
Cancers of the solid organs 28 3 10.7
HIV/AIDS 26 1 3.8
Solid organ transplantations
 10
 4
 40.0
Diabetes
 86
 8
 9.3
No known risk factor
 289
 12
 4.2
Total 531 61 11.5

*Calculated only for the 61 deaths reported in hospital records for which information about underlying diseases was available.

Main Article

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external